XTL Biopharmaceuticals Ltd (XTLB)
2.693
+0.04
(+1.62%)
USD |
NASDAQ |
May 17, 16:00
2.71
+0.02
(+0.63%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash Conversion Cycle (Quarterly)
Cash Conversion Cycle (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash Conversion Cycle (Quarterly) Data
Date | Value |
---|---|
September 30, 2013 | -- |
June 30, 2013 | -- |
Date | Value |
---|---|
March 31, 2013 | -- |
Cash Conversion Cycle Definition
The cash conversion cycle (CCC) is the theoretical amount of time between a company spending cash and receiving cash per each sale, output, unit of operation, etc. It is basically a measure of how long cash is tied up in working capital.
Cash Conversion Cycle (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash Conversion Cycle (Quarterly) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -- |
BioLine Rx Ltd | -- |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -- |